Viking Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:VKTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 21.96 M31.18 M52.33 M47.06 M94 M85.29 M 278.69 M Cash from investing activities -25.9 M-6.58 M63.24 M42.51 M160.03 M75.61 M 341.39 M Cash from financing activities 2.52 M1 M349 K507 K480 K75.1 M 76.44 M Free cash flow 21.96 M31.18 M52.33 M47.06 M94 M85.29 M 278.69 M

Noticias

Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?

Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026

American Express, Oracle among market cap stock movers on Monday

Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin

Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)

Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?

Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk

NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?

Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)

Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)

Las acciones de Fastly se disparan un 35 %; Aquí están 20 acciones que se están moviendo en premercado | Benzinga España

Cisco and Micron among market cap stock movers on Thursday